{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7277,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/2",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "appendix_disclosure",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/3",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "The slide outlines the status of THIO-101, 102, and 103 trials and mentions specific patent filings.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/4",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a Gantt-style layout to map drug candidates against clinical development stages.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/5",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 5,
          "beatId": "79eac8b2-69eb-42cc-94c1-b5b70805ff28",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "Slides 5-6 discuss the current state of cancer treatment and its limitations",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a chromosome icon for the lead asset and a fast-forward icon for the pipeline strategy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/6",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 5,
          "beatId": "79eac8b2-69eb-42cc-94c1-b5b70805ff28",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "Slides 5-6 discuss the current state of cancer treatment and its limitations",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/7",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 7,
          "beatId": "74474725-688d-4926-8ad3-c48ee709e5a0",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 7-10 introduce THIO and its mechanisms of action",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "why_now",
      "function": "establish_context",
      "notes": "The slide uses a three-column layout with circular callouts to present demographic and health statistics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/8",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-8",
      "loopMatches": [
        {
          "to": 9,
          "from": 8,
          "name": "Why Now",
          "slug": "15-why-now",
          "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
          "matchId": "ccc33018-f447-48b1-a7ff-aad25768e4d1",
          "evidence": "Slides 8-9 discuss the current state of cancer treatment and the need for new solutions",
          "position": 1,
          "objective": "Why is now the right time for THIO?",
          "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
          "confidence": 0.6,
          "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 7,
          "beatId": "74474725-688d-4926-8ad3-c48ee709e5a0",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 7-10 introduce THIO and its mechanisms of action",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "thesis_headline",
      "function": "establish_context",
      "notes": "This slide serves as a transition or key message reinforcement.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/9",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-9",
      "loopMatches": [
        {
          "to": 14,
          "from": 9,
          "name": "Pattern Hunter",
          "slug": "02-pattern-hunter",
          "bestFor": "Time-pressed audiences, building consensus, when data is strong",
          "matchId": "efef3358-ed9b-42fa-8406-e83983de324a",
          "evidence": "Slides 9-14 present data on THIO's efficacy in clinical trials",
          "position": 0,
          "objective": "Is THIO effective in clinical trials?",
          "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
          "confidence": 0.7,
          "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
        },
        {
          "to": 9,
          "from": 8,
          "name": "Why Now",
          "slug": "15-why-now",
          "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
          "matchId": "ccc33018-f447-48b1-a7ff-aad25768e4d1",
          "evidence": "Slides 8-9 discuss the current state of cancer treatment and the need for new solutions",
          "position": 1,
          "objective": "Why is now the right time for THIO?",
          "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
          "confidence": 0.6,
          "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 7,
          "beatId": "74474725-688d-4926-8ad3-c48ee709e5a0",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 7-10 introduce THIO and its mechanisms of action",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a visual comparison between telomere targeting (left) and PD-1/PD-L1 checkpoint inhibition (right).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/10",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-10",
      "loopMatches": [
        {
          "to": 14,
          "from": 9,
          "name": "Pattern Hunter",
          "slug": "02-pattern-hunter",
          "bestFor": "Time-pressed audiences, building consensus, when data is strong",
          "matchId": "efef3358-ed9b-42fa-8406-e83983de324a",
          "evidence": "Slides 9-14 present data on THIO's efficacy in clinical trials",
          "position": 0,
          "objective": "Is THIO effective in clinical trials?",
          "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
          "confidence": 0.7,
          "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 7,
          "beatId": "74474725-688d-4926-8ad3-c48ee709e5a0",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 7-10 introduce THIO and its mechanisms of action",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Slide highlights a strategic partnership/supply agreement as a form of business traction.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/11",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-11",
      "loopMatches": [
        {
          "to": 14,
          "from": 9,
          "name": "Pattern Hunter",
          "slug": "02-pattern-hunter",
          "bestFor": "Time-pressed audiences, building consensus, when data is strong",
          "matchId": "efef3358-ed9b-42fa-8406-e83983de324a",
          "evidence": "Slides 9-14 present data on THIO's efficacy in clinical trials",
          "position": 0,
          "objective": "Is THIO effective in clinical trials?",
          "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
          "confidence": 0.7,
          "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The chart shows tumor volume over time, highlighting the efficacy of the THIO + Atezo combination compared to controls.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/12",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-12",
      "loopMatches": [
        {
          "to": 14,
          "from": 9,
          "name": "Pattern Hunter",
          "slug": "02-pattern-hunter",
          "bestFor": "Time-pressed audiences, building consensus, when data is strong",
          "matchId": "efef3358-ed9b-42fa-8406-e83983de324a",
          "evidence": "Slides 9-14 present data on THIO's efficacy in clinical trials",
          "position": 0,
          "objective": "Is THIO effective in clinical trials?",
          "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
          "confidence": 0.7,
          "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide outlines a clinical trial process flow including randomization and expansion phases.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/13",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-13",
      "loopMatches": [
        {
          "to": 14,
          "from": 9,
          "name": "Pattern Hunter",
          "slug": "02-pattern-hunter",
          "bestFor": "Time-pressed audiences, building consensus, when data is strong",
          "matchId": "efef3358-ed9b-42fa-8406-e83983de324a",
          "evidence": "Slides 9-14 present data on THIO's efficacy in clinical trials",
          "position": 0,
          "objective": "Is THIO effective in clinical trials?",
          "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
          "confidence": 0.7,
          "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The table compares Cyramza+Docetaxel, Docetaxel alone, and THIO+Libtayo.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/14",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-14",
      "loopMatches": [
        {
          "to": 14,
          "from": 9,
          "name": "Pattern Hunter",
          "slug": "02-pattern-hunter",
          "bestFor": "Time-pressed audiences, building consensus, when data is strong",
          "matchId": "efef3358-ed9b-42fa-8406-e83983de324a",
          "evidence": "Slides 9-14 present data on THIO's efficacy in clinical trials",
          "position": 0,
          "objective": "Is THIO effective in clinical trials?",
          "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
          "confidence": 0.7,
          "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide highlights that THIO has a better safety profile than standard chemotherapy, which typically has 70-80% incidence of Grade 3-5 side effects.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/15",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "DCR stands for Disease Control Rate. The table compares historical clinical trial data (KEYNOTE 024, REVEL, RWD) against the company's own THIO-101 trial data.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/16",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Data presented in a table format with specific clinical definitions for DCR and treatment lines.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/17",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "DCR = Disease Control Rate. Data presented in three separate tables for different dose cohorts.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/18",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Clinical trial data visualization showing patient-level outcomes over time.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/19",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The chart tracks individual patient outcomes over time, including treatment status, response type, and study exit reasons.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/20",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The plot highlights long-term benefit post-therapy and low mortality rates in the cohort.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/21",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide shows a biological mechanism of action (MOA) validation using a dot plot to show TIFs increase over 72 hours.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/22",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide outlines a multi-stage clinical trial design (Part A/B to Part C) involving immune activation with various checkpoint inhibitors.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/23",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "why_now",
      "function": "show_traction",
      "notes": "The slide presents two line charts showing tumor volume reduction and long-term survival/rechallenge success.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/24",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The table compares three treatment regimens across four categories: Expected Efficacy, Safety Profile, Administration, and Trial of Reference.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/25",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The table compares historical standard of care data against planned THIO-102 trial outcomes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/26",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/27",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide presents two line charts showing tumor volume reduction over time for different treatment regimens in SCLC and HCC mouse models.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/28",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 29,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart shows a clear divergence between the control group (increasing tumor volume) and the THIO group (decreasing tumor volume to near zero).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/29",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-29",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide shows two line charts representing tumor volume over time in HCC models, highlighting the efficacy of THIO and THIO+Libtayo combinations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/30",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-30",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
      "docSlug": "246b804be07776f664c6b3d8600daf3e",
      "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
      "authorId": "maia-biotechnology",
      "authorName": "MAIA Biotechnology",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 31,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide outlines a clinical trial process flow from initial baskets through immune activation to a pivotal phase.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/31",
      "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
      "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-31",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}